Recent findings regarding the NLRP3 inflammasome regulatory mechanism have revealed that NLRP3 can trigger the PTEN/AKT and epithelial mesenchymal transition signaling pathways, which in turn induce glioma development, cell death, and spread [51]. This evidence concerns the gene NLRP3 and central nervous system cancer.